has vaccine antigen
vaccinated in route
immunizes host
Homo sapiens
spike glycoprotein (SARS-CoV-2)
subcutaneous route
oral route
hAd5-COVID-19
NCT04591717
vaccine
A SARS-CoV-2 human adenovirus serotype 5 (hAd5) vector vaccine with E1/E2b/E3 deletions expressing SARS-CoV-2 viral antigen spike fusion protein and nucleocapsid with an enhanced T-cell stimulation domain.
Philip Huang
COVID-19 recombinant adenoviral vector vaccine